Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic testing for hereditary breast cancer in Poland: 1998-2022. | Hered Cancer Clin Pract | 2023 | 37312208 | PubTator, text mining | PubMed |
| BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute. | PLoS One | 2023 | 37310942 | PubTator, text mining | PubMed |
| Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel. | Oncotarget | 2023 | 37306523 | PubTator, text mining | PubMed |
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells. | Int J Mol Sci | 2023 | 37298413 | PubTator, text mining | PubMed |
| Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing. | BMC Med Genomics | 2023 | 37296477 | PubTator, text mining | PubMed |
| Fatal sclerosing mesenteritis: a 7-year-old male autopsy case report. | Autops Case Rep | 2023 | 37292389 | PubTator, text mining | PubMed |
| The Impact of Germline Alterations in Appendiceal Adenocarcinoma. | Clin Cancer Res | 2023 | 37289003 | PubTator, text mining | PubMed |
| Distinctive Formation of a DNA-Protein Cross-Link during the Repair of DNA Oxidative Damage: Insights into Human Disease from MD Simulations and QM/MM Calculations. | J Am Chem Soc | 2023 | 37285289 | PubTator, text mining | PubMed |
| A holistic approach to maximise diagnostic output in trio exome sequencing. | Front Pediatr | 2023 | 37274821 | PubTator, text mining | PubMed |
| Genomics driven precision oncology in advanced biliary tract cancer improves survival. | Neoplasia | 2023 | 37267699 | PubTator, text mining | PubMed |
| Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report. | Anticancer Drugs | 2023 | 37265026 | PubTator, text mining | PubMed |
| Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines. | Br J Cancer | 2023 | 37258796 | PubTator, text mining | PubMed |
| Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. | Nat Commun | 2023 | 37258531 | PubTator, text mining | PubMed |
| Identification of the hub genes associated with prostate cancer tumorigenesis. | Front Oncol | 2023 | 37251946 | PubTator, text mining | PubMed |
| DNA damage repair proteins across the Tree of Life. | iScience | 2023 | 37250769 | PubTator, text mining | PubMed |
| Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit. | Int J Mol Sci | 2023 | 37240345 | PubTator, text mining | PubMed |
| DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC. | Int J Mol Sci | 2023 | 37240218 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. | Genes (Basel) | 2023 | 37239385 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. | Biomedicines | 2023 | 37239058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=23